These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients. Gómez-Puerta JA; Ortiz-Reyes B; Urrego T; Vanegas-García AL; Muñoz CH; González LA; Cervera R; Vásquez G Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812 [TBL] [Abstract][Full Text] [Related]
9. Urinary galectin-3 binding protein (G3BP) as a biomarker for disease activity and renal pathology characteristics in lupus nephritis. Ding H; Shen Y; Lin C; Qin L; He S; Dai M; Okitsu SL; DeMartino JA; Guo Q; Shen N Arthritis Res Ther; 2022 Mar; 24(1):77. PubMed ID: 35346341 [TBL] [Abstract][Full Text] [Related]
10. The role of urinary neutrophil gelatinase-associated lipocalin in lupus nephritis. Alharazy SM; Kong NC; Mohd M; Shah SA; Abdul Gafor AH; Ba'in A Clin Chim Acta; 2013 Oct; 425():163-8. PubMed ID: 23954775 [TBL] [Abstract][Full Text] [Related]
11. U-KIM-1 as a predictor of treatment response in lupus nephritis. Nozaki Y; Shiga T; Ashida C; Tomita D; Itami T; Kishimoto K; Kinoshita K; Matsumura I Lupus; 2023 Jan; 32(1):54-62. PubMed ID: 36305170 [TBL] [Abstract][Full Text] [Related]
12. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [TBL] [Abstract][Full Text] [Related]
13. Clinical measurement of lupus nephritis activity is inferior to biomarker-based activity assessment using the renal activity index for lupus nephritis in childhood-onset systemic lupus erythematosus. Aljaberi N; Wenderfer SE; Mathur A; Qiu T; Jose S; Merritt A; Rose J; Devarajan P; Huang B; Brunner H Lupus Sci Med; 2022 May; 9(1):. PubMed ID: 35568436 [TBL] [Abstract][Full Text] [Related]
14. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus. Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728 [TBL] [Abstract][Full Text] [Related]
16. Urinary neutrophil gelatinase-associated lipocalin as a marker of severe lupus nephritis in children. Hammad A; Mosaad Y; Elhanbly S; Youssef H; El Refaaey A; Elhusseini F; Bakr A Lupus; 2013 Apr; 22(5):486-91. PubMed ID: 23554037 [TBL] [Abstract][Full Text] [Related]
17. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus. Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504 [TBL] [Abstract][Full Text] [Related]
19. Association of Urine sCD163 With Proliferative Lupus Nephritis, Fibrinoid Necrosis, Cellular Crescents and Intrarenal M2 Macrophages. Zhang T; Li H; Vanarsa K; Gidley G; Mok CC; Petri M; Saxena R; Mohan C Front Immunol; 2020; 11():671. PubMed ID: 32351512 [TBL] [Abstract][Full Text] [Related]
20. Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis. Nozaki Y; Kinoshita K; Yano T; Shiga T; Hino S; Niki K; Kishimoto K; Funauchi M; Matsumura I Lupus; 2014 Jul; 23(8):769-77. PubMed ID: 24598218 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]